BEATHeartBeam, Inc.

BEAT Stock Price, Valuation & Chart | HeartBeam, Inc.

$0.450+0.00 (-1.01%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Healthcare Information Services BEAT intrinsic value BEAT calculated fair value vs price

Overview Financials Dividends Ratios

BEAT Historical price chart

BEAT Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization24.98M

PE Ratio-0.88

EPS-0.51

Trading Volume391.07K

Today's High/Low0.47/0.45

Dividend Yield0.00

52 Week High/Low4.0/0.45

Shares Outstanding55.51M

BEAT Financial Statement

BEAT Analyst ratings

BEAT Analysis & performance metrics

BEAT Company profile

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility…

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram…

BEAT Management team

Name

Position

Timothy CruickshankCFO

Chief Financial Officer

Lance Myers Ph.D.

Chief Artificial Intelligence Scientist

Kenneth PersenCTO

Chief Technology Officer

Branislav Vajdic Ph.D.CTO

Founder, President & Director

Robert P. EnoCEO

Chief Executive Officer, Chief Business Officer & Director

Peter J. Fitzgerald FACC, M.D., Ph.D.

Member of Scientific Advisory Board & Chief Medical Officer

Richa Gujarati

Senior Vice President of Product

Richard M. Ferrari

Executive Chairman

Name

Position

Timothy CruickshankCFO

Chief Financial Officer

Lance Myers Ph.D.

Chief Artificial Intelligence Scientist

Kenneth PersenCTO

Chief Technology Officer

Branislav Vajdic Ph.D.CTO

Founder, President & Director

Robert P. EnoCEO

Chief Executive Officer, Chief Business Officer & Director

Peter J. Fitzgerald FACC, M.D., Ph.D.

Member of Scientific Advisory Board & Chief Medical Officer

Richa Gujarati

Senior Vice President of Product

Richard M. Ferrari

Executive Chairman

Management Team

Timothy CruickshankCFO

Chief Financial Officer

Lance Myers Ph.D.

Chief Artificial Intelligence Scientist

Kenneth PersenCTO

Chief Technology Officer

Branislav Vajdic Ph.D.CTO

Founder, President & Director

Robert P. EnoCEO

Chief Executive Officer, Chief Business Officer & Director

Peter J. Fitzgerald FACC, M.D., Ph.D.

Member of Scientific Advisory Board & Chief Medical Officer

Richa Gujarati

Senior Vice President of Product

Richard M. Ferrari

Executive Chairman

Management

Timothy CruickshankCFO

Chief Financial Officer

Lance Myers Ph.D.

Chief Artificial Intelligence Scientist

Kenneth PersenCTO

Chief Technology Officer

Branislav Vajdic Ph.D.CTO

Founder, President & Director

Robert P. EnoCEO

Chief Executive Officer, Chief Business Officer & Director

Peter J. Fitzgerald FACC, M.D., Ph.D.

Member of Scientific Advisory Board & Chief Medical Officer

Richa Gujarati

Senior Vice President of Product

Richard M. Ferrari

Executive Chairman

Total 8 executives

BEAT Frequently asked questions

What is HeartBeam, Inc. (BEAT) Stock Price?

Current stock price of HeartBeam, Inc. (BEAT) stock is $0.450. The stock price is -1.01% lower in the session. The intraday range can be seen from this page. Volume of HeartBeam, Inc. (BEAT) stock is 391.07K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the HeartBeam, Inc. (BEAT) stock price going up or down today?

The stock price of HeartBeam, Inc. (BEAT) can change with earnings, company news, and overall market sentiment. HeartBeam, Inc. operates in the Healthcare / Medical - Healthcare Information Services market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the HeartBeam, Inc. stock expensive at its current price?

Whether HeartBeam, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BEAT on this page is -0.88. EPS on this page is -0.51. Compare those figures with peers and growth expectations before deciding if the current HeartBeam, Inc. price is justified.

How has the stock price of HeartBeam, Inc. (BEAT) performed historically?

Historical performance for HeartBeam, Inc. (BEAT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BEAT reacted to past earnings and market events.

Should I buy HeartBeam, Inc. (BEAT) stock, at this price?

Buying HeartBeam, Inc. (BEAT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.